News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
VITULLO NICOLE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 2,750 shares
@ $0
Granted 12,375 options to buy
@ $10.4, valued at
$128.7k
|
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 16,500 options to buy
@ $12.6, valued at
$207.9k
|
|
| 11/06/2020 |
4/A
| VITULLO NICOLE (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $0 |
|
| 05/29/2020 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 6,106 shares
@ $0 |
|
| 01/29/2020 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 36,431 shares
@ $6.3, valued at
$229.5k
Disposed/sold 3,393,382 shares
@ $6.3, valued at
$21.4M
Disposed/sold 25,159 shares
@ $6.3, valued at
$158.5k
Disposed/sold 50,000 options to buy
@ $3.1, valued at
$155k
Disposed/sold 20,000 options to buy
@ $7.59, valued at
$151.8k
Disposed/sold 20,000 options to buy
@ $8.64, valued at
$172.8k
Disposed/sold 25,000 options to buy
@ $3.02, valued at
$75.5k
Disposed/sold 25,000 options to buy
@ $13.24, valued at
$331k
Disposed/sold 30,000 options to buy
@ $7.54, valued at
$226.2k
Disposed/sold 30,000 options to buy
@ $4.09, valued at
$122.7k
Disposed/sold 30,000 options to buy
@ $2.9, valued at
$87k
|
|
| 01/10/2020 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.07, valued at
$207k
|
|
| 08/08/2019 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 250,000 shares
@ $4, valued at
$1M
Bought 187,500 options to buy
@ $4.4, valued at
$825k
|
|
| 05/31/2019 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 4,967 shares
@ $0 |
|
| 05/13/2019 |
3
| DP VIII Associates, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
| 05/13/2019 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
| 03/21/2019 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Disposed of 1,101,080 shares
@ $0
Acquired 17,790 shares
@ $0
Sold 13,629 shares
@ $44.66, valued at
$608.7k
Sold 1,700 shares
@ $45.25, valued at
$76.9k
Disposed of 17,790 shares
@ $0
Acquired 1,356 shares
@ $0 |
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 42,000 options to buy
@ $2.18, valued at
$91.6k
|
|
| 08/27/2018 |
4
| DOMAIN PARTERS VII L P (10% Owner) has filed a Form 4 on OBALON THERAPEUTICS INC|
Txns:
| Bought 1,648,359 shares
@ $1.82, valued at
$3M
|
|
| 08/27/2018 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on BioNano Genomics, Inc|
Txns:
| Converted 4,386 shares
@ $0
Converted 2,505 shares
@ $4.59, valued at
$11.5k
Converted 50,532 preferred shares
@ $0
Converted 22,161 preferred shares
@ $0
Converted 40,268 preferred shares
@ $0
Converted 47,460 preferred shares
@ $0
Converted 27,328 preferred shares
@ $0
Converted convertible notes
@ $0 |
|
| 08/27/2018 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on BioNano Genomics, Inc|
Txns:
| Converted 591,184 shares
@ $0
Converted 337,694 shares
@ $4.59, valued at
$1.6M
Bought 15,000 shares
@ $6.125, valued at
$91.9k
Converted 6,810,098 preferred shares
@ $0
Converted 2,986,762 preferred shares
@ $0
Converted 5,426,808 preferred shares
@ $0
Converted 6,396,105 preferred shares
@ $0
Converted 3,682,919 preferred shares
@ $0
Converted convertible notes
@ $0
Bought 15,000 options to buy
@ $6.125, valued at
$91.9k
|
|
| 08/21/2018 |
3
| DP VIII Associates, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 08/21/2018 |
3
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 08/21/2018 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
| 06/26/2018 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Disposed of 21,471 shares
@ $0
Acquired 3,846 shares
@ $0 |
|
| 06/04/2018 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed of 25,000 shares
@ $0
Acquired 5,000 shares
@ $0 |
|
| 05/25/2018 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 10,100 options to buy
@ $38.32, valued at
$387k
|
|
| 02/13/2018 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $2.9, valued at
$87k
|
|
| 01/26/2018 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Disposed of 850,000 shares
@ $0
Acquired 8,500 shares
@ $0
Paid exercise price by delivering 6,814 shares
@ $71.82, valued at
$489.4k
Paid exercise price by delivering 117 shares
@ $71.82, valued at
$8.4k
Sold 11,674 shares
@ $71.79, valued at
$838.1k
Disposed of 8,500 shares
@ $0
Acquired 645 shares
@ $0
Exercised 70,042 options to buy
@ $6.99, valued at
$489.6k
Exercised 1,193 options to buy
@ $6.99, valued at
$8.3k
|
|
| 01/24/2018 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Disposed of 2,250 shares
@ $0
Acquired 2,250 shares
@ $0 |
|
| 12/20/2017 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Converted 12,444 shares
@ $3.19, valued at
$39.7k
Granted 282 shares
@ $0
Converted 368 options to buy
@ $3.19, valued at
$1.2k
|
|
| 12/20/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Converted 1,678,432 shares
@ $3.19, valued at
$5.4M
Granted 37,890 shares
@ $0
Converted 49,632 options to buy
@ $3.19, valued at
$158.3k
|
|
| 12/13/2017 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 47,963 shares
@ $0 |
|
| 12/13/2017 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 15,731 shares
@ $0 |
|
| 12/13/2017 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 1,857,036 shares
@ $0
Disposed/sold 20,150 options to buy
@ $0.67, valued at
$13.5k
|
|
|
|
|